2025
Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study
Shoukat A, Wells C, Shin T, Potter-Schwartz L, Galvani A, Moghadas S. Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study. The Lancet Regional Health - Americas 2025, 44: 101033. PMID: 40046840, PMCID: PMC11880592, DOI: 10.1016/j.lana.2025.101033.Peer-Reviewed Original ResearchInvasive meningococcal diseaseInvasive meningococcal disease casesVaccination scheduleVaccine uptakeAlternative schedulesMenACWY vaccination programCase fatality rateHigh-risk adolescentsVaccine introductionBooster doseIMD casesSerogroup CCompare outcomesMenACWY vaccineAsymptomatic infectionImmunization PracticesMeningococcal diseaseVaccine effectivenessIMD incidenceDoseSerogroups AVaccineStudy periodVaccination programIncrease vaccine uptakeImpact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Du Z, Pandey A, Moghadas S, Bai Y, Wang L, Matrajt L, Singer B, Galvani A. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nature Medicine 2025, 31: 647-652. PMID: 39789324, PMCID: PMC11835734, DOI: 10.1038/s41591-024-03431-7.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusSyncytial virusRSV diseaseImpact of vaccinationBurden of respiratory syncytial virusVaccination of pregnant womenRSV-related mortalityProtein-based vaccinesVaccination of older adultsRSV vaccinePregnant womenSeasonal influenzaVaccine uptake ratesInfant hospitalizationClinical trialsPrefusion FHospital costsInfantsHealth burdenAdult immunizationVaccineOlder adultsHospitalEnhanced uptakeHigh-income countries
2010
Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?
Bauch CT, Li M, Chapman G, Galvani AP. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? The Lancet Infectious Diseases 2010, 10: 133-137. PMID: 20113982, DOI: 10.1016/s1473-3099(10)70004-9.Peer-Reviewed Original ResearchConceptsCervical cancerVaccinated womenVaccine coverageEffective cervical screening programmesHuman papillomavirus vaccinationCervical screening programmeHigh-risk typesIntroduction of vaccinesPapillomavirus vaccinationOncogenic typesCervical screeningOpportunistic screeningScreening programPrevents infectionCancerVaccineIncidenceContinued screeningWomenVaccinationScreeningPopulationDisease incidenceInfection
2008
Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets
Basu S, Chapman GB, Galvani AP. Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proceedings Of The National Academy Of Sciences Of The United States Of America 2008, 105: 19018-19023. PMID: 19015536, PMCID: PMC2596236, DOI: 10.1073/pnas.0808114105.Peer-Reviewed Original ResearchConceptsHPV vaccinationCervical cancerVaccination levelsVaccination targetsCervical cancer prevention programsHuman papillomavirus vaccineVaccine-eligible childrenCancer prevention programsHealth-related utilityVaccine recipientsGenital wartsPapillomavirus vaccineVaccination recommendationsVaccination goalsVaccine risksPrevention programsVaccinationSexual activityCancerCoverage planCost subsidizationSurvey respondentsVaccineEpidemiologyIncidence
2007
Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum
Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings Of The National Academy Of Sciences Of The United States Of America 2007, 104: 5692-5697. PMID: 17369367, PMCID: PMC1838447, DOI: 10.1073/pnas.0606774104.Peer-Reviewed Original ResearchConceptsInfluenza vaccinationInfluenza vaccination policiesVaccine allocation strategiesEpidemic influenzaPandemic influenzaInfluenza mortalityVaccination levelsVaccination programVaccination strategiesVaccination policyInfluenza transmissionVaccinationGreater riskDisease controlInfluenzaMortalityChildrenQuestionnaire dataMorbidityVaccine
2003
Ecological and immunological determinants of influenza evolution
Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003, 422: 428-433. PMID: 12660783, DOI: 10.1038/nature01509.Peer-Reviewed Original ResearchConceptsNew avian influenzaHost immune systemStrain-transcending immunityImmunological factorsInfluenza ANew vaccinesAnnual epidemicsAntigenic shiftImmune systemAntigenic changesEpidemic formHigh transmissibilityImmunological determinantsInfluenzaAvian influenzaGlobal pandemicInfluenza evolutionViral evolutionViral diversityEpidemiological dynamicsMorbidityVaccineMortalitySubtypesImmunity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply